ResearcherTokyo Medical UniversityNo recent work listed

Norifumi Kennoki

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6592-3429; OpenAlex author ID A5089874795. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2016: 1 paper

Papers 1

Feasibility of intensity-modulated radiotherapy combined with gemcitabine and S-1 for patients with pancreatic cancer. Co-author DOI 10.3892/mco.2015.664 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yuichi Hosokawa · 1 shared paper, 2016 · strength 0.06
- Paper Feasibility of intensity-modulated radiotherapy combined with gemcitabine and S-1 for patients with pancreatic cancer. DOI 10.3892/mco.2015.664 ↗
Koichi Tokuuye · 1 shared paper, 2016 · strength 0.06
- Paper Feasibility of intensity-modulated radiotherapy combined with gemcitabine and S-1 for patients with pancreatic cancer. DOI 10.3892/mco.2015.664 ↗
Yuichi Nagakawa · 1 shared paper, 2016 · strength 0.06
- Paper Feasibility of intensity-modulated radiotherapy combined with gemcitabine and S-1 for patients with pancreatic cancer. DOI 10.3892/mco.2015.664 ↗
Akihiko Tsuchida · 1 shared paper, 2016 · strength 0.06
- Paper Feasibility of intensity-modulated radiotherapy combined with gemcitabine and S-1 for patients with pancreatic cancer. DOI 10.3892/mco.2015.664 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.